Prognostic Factors in the Era of Targeted Therapies in CLL

Current Hematologic Malignancy Reports
Prajwal Boddu, Alessandra Ferrajoli

Abstract

Chronic lymphocytic leukemia is heterogeneous disease characterized by a variable clinical course that is greatly influenced by various patient and disease characteristics. Over the last two decades, advent of new diagnostic methodologies has led to the identification of several factors of prognostic and predictive relevance. Furthermore, recent advances in next-generation sequencing techniques has identified recurrent novel mutations in NOTCH1, SF3B1, BIRC3, and ATM genes whose role as prognostic and predictive markers is currently being investigated. These biologic markers carry new prognostic information and their incorporation into prognostic scoring systems will likely lead to refined multi-parameter risk models. While the prognostic impact of many of the most commonly used markers on clinical outcomes in patients treated with chemo-immunotherapy is well documented, it is important to review their predictive and prognostic role in the era of novel targeted therapies. This article will discuss the currently available information on the clinical relevance of prognostic markers in patients treated with novel targeted therapies.

References

Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
May 2, 2003·The New England Journal of Medicine·Marta CrespoEmili Montserrat
Feb 25, 2005·The New England Journal of Medicine·Nicholas ChiorazziManlio Ferrarini
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J KeatingHagop Kantarjian
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander KröberStephan Stilgenbauer
Jun 27, 2007·British Journal of Haematology·Ludger SellmannRalf Küppers
Jul 20, 2007·American Journal of Clinical Pathology·Beverly P NelsonLoAnn C Peterson
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Belinda AustenTatjana Stankovic
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Davide RossiGianluca Gaidano
Jul 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephan StilgenbauerUNKNOWN German Chronic Lymphocytic Leukemia Study Group
Jul 27, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Joan H AdmirandLynne V Abruzzo
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thorsten ZenzStephan Stilgenbauer
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David GonzalezGareth J Morgan
Jun 15, 2011·The Journal of Experimental Medicine·Giulia FabbriGianluca Gaidano
Jul 19, 2011·Blood·Fabio MalavasiNicholas Chiorazzi
Aug 13, 2011·Clinical Chemistry·Kanti R Rai, Preetesh Jain
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William G WierdaMichael J Keating

❮ Previous
Next ❯

Citations

Sep 29, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnon P KaterJohn F Seymour
Aug 17, 2018·International Journal of Molecular Sciences·Simone MirabiliiAgostino Tafuri
Oct 4, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beatrice Del PapaPaolo Sportoletti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.